DOLIPRANE 1000 mg, comprimé — plaquette(s) thermoformée(s) PVC-aluminium de 8 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

CIP13 3400935955838
CIP7 3595583
CIS 60234100

What the source publishes

Holder: OPELLA HEALTHCARE FRANCE
Active ingredients: PARACÉTAMOL
Form: comprimé
Package: plaquette(s) thermoformée(s) PVC-aluminium de 8 comprimé(s)
Routes: orale
Administrative status: authorised
Marketing status: Déclaration de commercialisation
Authorised on: 2002-07-09

Names this record is found by

Complete source data

fr:ansm:packages:3400935955838

{
  "cis": "60234100",
  "cip7": "3595583",
  "form": "comprimé",
  "name": "DOLIPRANE 1000 mg, comprimé — plaquette(s) thermoformée(s) PVC-aluminium de 8  comprimé(s)",
  "cip13": "3400935955838",
  "holder": "OPELLA HEALTHCARE FRANCE",
  "routes": [
    "orale"
  ],
  "holders": [
    "OPELLA HEALTHCARE FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "2.18",
  "authorisedOn": "2002-07-09",
  "compositions": [
    {
      "name": "PARACÉTAMOL",
      "nature": "SA",
      "strength": "1000 mg",
      "linkageNumber": "1",
      "substanceCode": "02202",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": null,
  "dispensingFee": "1.02",
  "medicinePrice": "1.16",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "DOLIPRANE 1000 mg, comprimé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-03",
    "CIS_CIP_bdpm": "2026-11-09",
    "CIS_CPD_bdpm": "2026-11-03",
    "CIS_COMPO_bdpm": "2026-11-03"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC-aluminium de 8  comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2003-01-02",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "unknown",
  "activeIngredientNames": [
    "PARACÉTAMOL"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Public medicines database (BDPM)

Source : Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie — dates de mise à jour dans publicationDates ; https://base-donnees-publique.medicaments.gouv.fr

Retrieved: November 9, 2026
Licence: Licence Ouverte 1.0
Source id: fr.ansm.bdpm

Official source

What this source does not establish

Complete BDPM export, not a history of every French authorisation: the help page describes currently marketed medicines and those discontinued within five years, while the reviewed v4/v5 file specifications still say two years.
CIS identifies the specialty, CIP13 and CIP7 its presentation. All specialties remain searchable; prescriptions use named CIP13 presentations, and the four current presentations without a matching specialty are flagged, never matched by name or given invented parent data.
CIS_CPD publishes explicit dispensing conditions, not an OTC flag: list I, list II, narcotics and explicit prescribing or dispensing restrictions are prescription-or-restricted; absence of a condition stays unknown. No patient eligibility is assessed.
The effective pack administrative status preserves explicit licence suspension, withdrawal or cancellation over an active presentation. An archived or missing parent licence cannot establish authorisation; an explicitly cancelled presentation remains cancelled. Marketing declarations do not establish pharmacy stock.
The headerless files have the same strict positional schemas in the reviewed v4/v5 specifications. CIS, COMPO and CPD are Windows-1252, CIP is UTF-8; therapeutic fractions are FT in the export but ST in the specification, and three CPD CR-only blank lines are counted without dropping any condition.
The linked October 2011 Licence Ouverte v1.0 permits commercial redistribution and derived information with source and update-date attribution. BDPM’s download terms also require preservation of meaning, freshness checks and no suggestion of ANSM/HAS/Assurance Maladie endorsement.
SmPCs and patient leaflets are not in these bulk files: no document contents or guessed document URLs are collected. Safety information, shortages, HAS assessments and generic-group overlays are not collected.

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

Get your free API key Read the reference

GET /v1/drugs/record

curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400935955838"